Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Strong“
Suchtreffer
Begriffe & Kennungen
Aripiprazole Zentiva · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenArtesunate Amivas · 4.5 · Co-administration of intravenous artesunate with strong inhibitors of UGT enzymes (e.g. axitinib, vandetanib,
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.3 · Co-administration with medicinal products that are strong inducers of CYP3A4 due to the potential for loss of
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Ritonavir is a strong P-gp inhibitor.
Eintrag öffnenBalversa · 4.5 · Grapefruit or Seville oranges should be avoided while taking Balversa due to strong CYP3A4 inhibition (see sec
Eintrag öffnenBalversa · 4.5 · Moderate CYP2C9 or strong CYP3A4 inhibitors Co-administration with a moderate CYP2C9 or strong CYP3A4 inhibito
Eintrag öffnenBalversa · 4.5 · Strong or moderate CYP3A4 inducers Co-administration with carbamazepine, a strong CYP3A4 and weak CYP2C9 induc
Eintrag öffnenBetmiga · 4.5 · 30 concomitantly receiving strong CYP3A inhibitors, such as itraconazole, ketoconazole, ritonavir and clarithr
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inhibitors Mirabegron exposure (AUC) was increased 1.8-fold in the presence of the strong inh
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inhibitors Mirabegron exposure (AUC) was increased 1.8-fold in the presence of the strong inh
Eintrag öffnenBosulif · 4.5 · CYP3A inducers The concomitant use of bosutinib with strong CYP3A inducers (including, but not limited to carb
Eintrag öffnenBosulif · 4.5 · CYP3A inhibitors The concomitant use of bosutinib with strong CYP3A inhibitors (including, but not limited to
Eintrag öffnenBosulif · 4.5 · If a strong or moderate CYP3A inhibitor must be administered during bosutinib treatment, an interruption of bo
Eintrag öffnenBosulif · 4.5 · In a study of 24 healthy subjects in whom 5 daily doses of 400 mg ketoconazole (a strong CYP3A inhibitor) were
Eintrag öffnenBraftovi · 4.5 · CYP substrates Encorafenib is a strong inducer of CYP3A4. Concomitant use with agents that are substrates of C
Eintrag öffnenBraftovi · 4.5 · CYP3A4 inducers Co-administration of encorafenib with a strong CYP3A4 inducer was not assessed in a clinical s
Eintrag öffnenBraftovi · 4.5 · CYP3A4 inhibitors Co-administration of moderate (diltiazem) and strong (posaconazole) CYP3A4 inhibitors with s
Eintrag öffnenBrilique · 4.5 · CYP3A4 inhibitors • Strong CYP3A4 inhibitors – Co-administration of ketoconazole with ticagrelor increased the
Eintrag öffnenBrilique · 4.5 · CYP3A4 inhibitors • Strong CYP3A4 inhibitors – Co-administration of ketoconazole with ticagrelor increased the
Eintrag öffnenBrilique · 4.5 · CYP3A4 inhibitors • Strong CYP3A4 inhibitors – Co-administration of ketoconazole with ticagrelor increased the
Eintrag öffnen